Generation Bio’s LNP DNA-Delivery Platform Gets Big Boost From Moderna

 
• By Alaric DeArment

The company aims to deliver DNA via lipid nanoparticles as well as delivering LNPs systemically to tissues beyond the liver and spleen, which the CEO called a “frontier” in an interview.

Moderna signed a deal with Generation Bio for its lipid nanoparticle and DNA-delivery technology • Source: Shutterstock

More from Deals

More from Business